Evidence map›Paper›PMID 21673658›Full record

ArticleThe EMBO journal2011

The Sm-like RNA chaperone Hfq mediates transcription antitermination at Rho-dependent terminators.

Makhlouf Rabhi, Olivier Espéli, Annie Schwartz, Bastien Cayrol, A Rachid Rahmouni, Véronique Arluison, Marc Boudvillain

Abstract read
In one paragraph

Article in The EMBO journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Transcription of Bacterial Chromatin.Journal of molecular biology · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Makhlouf RabhiCentre de Biophysique Moléculaire, CNRS UPR4301, rue Charles Sadron, Orléans Cedex 2, France.
Olivier Espéli
Annie Schwartz
Bastien Cayrol
A Rachid Rahmouni
Véronique Arluison
Marc Boudvillain
Centre National de la Recherche Scientifique · FRUniversité d'Orléans · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Escherichia coli, the essential motor protein Rho promotes transcription termination in a tightly controlled manner that is not fully understood. Here, we show that the general post-transcriptional regulatory protein Hfq associates with Rho to regulate Rho function. The Hfq:Rho complex can be further stabilized by RNA bridging both factors in a configuration that inhibits the ATP hydrolysis and duplex unwinding activities of Rho and that mediates transcription antitermination at Rho-dependent terminators in vitro and in vivo. Antitermination at a prototypical terminator (λtR1) requires Hfq binding to an A/U-rich transcript region directly upstream from the terminator. Antitermination is modulated by trans-acting factors (NusG or nucleic acid competitors) that affect Hfq association with Rho or RNA. These data unveil a new Hfq function and a novel transcription regulatory mechanism with potentially important implications for bacterial RNA metabolism, gene silencing, and pathogenicity.

Indexed as

Gene Expression Regulation, BacterialTerminator Regions, GeneticTranscription, GeneticAdenosine TriphosphatasesBase SequenceElectrophoretic Mobility Shift AssayEscherichia coliEscherichia coli ProteinsHost Factor 1 ProteinMolecular ChaperonesMolecular Sequence DataPeptide Elongation FactorsRNA, BacterialRNA HelicasesTranscription FactorsAdenosine TriphosphatasesEscherichia coli ProteinsHfq protein, E coliHost Factor 1 ProteinMolecular ChaperonesNusG protein, E coliPeptide Elongation FactorsRho protein, E coliRNA, BacterialRNA HelicasesTranscription Factors

Identifiers

PMID21673658
PMCPMC3160251
OpenAlexW2127375478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.